Manulife (Manufacturers Life Insurance)
KYNB

Manulife (Manufacturers Life Insurance)’s Kyntra Bio KYNB Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,210
Closed -$71.1K – 2997
2024
Q1 		$71.1K Buy
+1,210
New +$52.1K ﹤0.01% 2854
2023
Q3 		– Sell
-1,475
Closed -$99.6K – 2988
2023
Q2 		$99.6K Sell
1,475
-808
-35% -$334K ﹤0.01% 2849
2023
Q1 		$1.07M Sell
2,283
-809
-26% -$428K ﹤0.01% 1605
2022
Q4 		$1.23M Buy
3,092
+1,677
+119% +$642K ﹤0.01% 1529
2022
Q3 		$460K Sell
1,415
-33
-2% -$10.6K ﹤0.01% 2035
2022
Q2 		$382K Sell
1,448
-9
-0.6% -$2.3K ﹤0.01% 2224
2022
Q1 		$438K Sell
1,457
-338
-19% -$118K ﹤0.01% 2279
2021
Q4 		$633 Sell
1,795
-43
-2% -$13.4K ﹤0.01% 2112
2021
Q3 		$470K Sell
1,838
-112
-6% -$39.7K ﹤0.01% 2335
2021
Q2 		$1.3M Buy
1,950
+46
+2% +$26.5K ﹤0.01% 1829
2021
Q1 		$1.65M Sell
1,904
-116
-6% -$124K ﹤0.01% 1629
2020
Q4 		$1.87M Buy
2,020
+73
+4% +$76.7K ﹤0.01% 1556
2020
Q3 		$2M Sell
1,947
-32
-2% -$34.4K ﹤0.01% 1423
2020
Q2 		$2.01M Sell
1,979
-20
-1% -$18.6K ﹤0.01% 1398
2020
Q1 		$1.74M Buy
1,999
+131
+7% +$130K ﹤0.01% 1337
2019
Q4 		$2M Sell
1,868
-57
-3% -$58.2K ﹤0.01% 1397
2019
Q3 		$1.82M Sell
1,925
-13
-0.7% -$14.3K ﹤0.01% 1400
2019
Q2 		$2.19M Sell
1,938
-53
-3% -$58K ﹤0.01% 1357
2019
Q1 		$2.71M Sell
1,991
-70
-3% -$94.9K ﹤0.01% 1352
2018
Q4 		$2.38M Buy
2,061
+118
+6% +$133K ﹤0.01% 1341
2018
Q3 		$2.95M Sell
1,943
-273
-12% -$420K ﹤0.01% 1366
2018
Q2 		$3.47M Buy
2,216
+135
+6% +$176K ﹤0.01% 1359
2018
Q1 		$2.4M Sell
2,081
-47
-2% -$61.9K ﹤0.01% 1441
2017
Q4 		$2.52M Buy
2,128
+115
+6% +$144K ﹤0.01% 1406
2017
Q3 		$2.71M Buy
2,013
+162
+9% +$171K ﹤0.01% 1347
2017
Q2 		$1.5M Buy
1,851
+201
+12% +$140K ﹤0.01% 1583
2017
Q1 		$1.02M Buy
1,650
+193
+13% +$118K ﹤0.01% 1727
2016
Q4 		$779K Buy
1,457
+1
+0.1% +$499 ﹤0.01% 1803
2016
Q3 		$753K Buy
1,456
+3
+0.2% +$1.41K ﹤0.01% 1810
2016
Q2 		$596K Buy
1,453
+158
+12% +$72.3K ﹤0.01% 1918
2016
Q1 		$667K Buy
1,295
+21
+2% +$10.5K ﹤0.01% 1812
2015
Q4 		$970 Buy
1,274
+13
+1% +$8.63K ﹤0.01% 1639
2015
Q3 		$691 Buy
1,261
+27
+2% +$16.4K ﹤0.01% 1797
2015
Q2 		$725 Buy
1,234
+993
+412% +$578K ﹤0.01% 1870
2015
Q1 		$189 Buy
241
+151
+168% +$117K ﹤0.01% 2774
2014
Q4 		$62 Buy
+90
New +$57.9K ﹤0.01% 3185

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KYNB Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,210 shares — an estimated $71.1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in KYNB in Q4 2014 and held it in 36 quarters. The position peaked at $3.47M in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,210 Kyntra Bio shares in Q2 2024, an estimated $71.1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kyntra Bio in Q4 2014 and held it in 36 quarters.
  • Manulife (Manufacturers Life Insurance)'s Kyntra Bio position peaked at $3.47M in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.